"/> Novus Biologicals™ Peptide bloquant d’anticorps TA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps TAK1

Réf. : BL-RE-043718Réf. fabricant : 18270786 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
6885
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76441. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 14 amino acids near the amino terminus of human TAK1 (NT).

Points forts

Source

Synthetic

(Accession #: BAA25025) The TAK1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-043718
Réf. fabricant18270786
Gene ID (Entrez)6885
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76441. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneEC 2.7.11, EC 2.7.11.25, MEKK7, mitogen-activated protein kinase kinase kinase 7, TAK1/MAP3K7, TAK1TGF1a, TGF-beta activated kinase 1, TGF-beta-activated kinase 1, Transforming growth factor-beta-activated kinase 1
Symbole de gène(s)MAP3K7
Type de produitTAK1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne14 amino acids near the amino terminus of human TAK1 (NT)
Une question, une configuration particulière ?
Contactez-nous pour un devis.